Journal article
No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia
- Abstract:
-
Objectives: Current guidelines recommend broad-spectrum antibiotics for high-severity community-acquired pneumonia (CAP), potentially contributing to antimicrobial resistance (AMR). We aim to compare outcomes in CAP patients treated with amoxicillin (narrowspectrum) versus co-amoxiclav (broad-spectrum), to understand if narrow-spectrum antibiotics could be used more widely.
Methods: We analysed electronic health records from adults (≥16y) admit...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 815.9KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.jinf.2024.106161
Authors
Bibliographic Details
- Publisher:
- Elsevier
- Journal:
- Journal of Infection More from this journal
- Volume:
- 88
- Issue:
- 6
- Article number:
- 106161
- Publication date:
- 2024-04-23
- Acceptance date:
- 2024-04-16
- DOI:
- EISSN:
-
1532-2742
- ISSN:
-
0163-4453
Item Description
- Language:
-
English
- Keywords:
- Pubs id:
-
1990417
- Local pid:
-
pubs:1990417
- Deposit date:
-
2024-04-16
Terms of use
- Copyright holder:
- Wei et al.
- Copyright date:
- 2024
- Rights statement:
- © 2024 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record